The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
Corrigan Minehan Heart Center
Dobutamine Stress Echocardiogram
Explore This Procedure
About This Procedure
A dobutamine stress echocardiogram (DSE) is a test performed to evaluate your heart. The test involves an echocardiogram, which is an ultrasound of your heart, an electrocardiogram (ECG), and the use of a medication called dobutamine.
The DSE compares the performance of your heart at rest to the performance of your heart during exercise, or stress. This can be helpful in the diagnosis of cardiac disease in the early stages of development or to assess the progress of patients with known cardiac disease. Dobutamine is used to simulate your heart’s functioning during exercise and is often used when a patient cannot perform strenuous exercise or because the physician specifically ordered this test.
Before the Test
- Take your medications as scheduled
- If you are taking a Beta-Blocker, you may be asked not to take it 24 to 48 hours before the test. Your physician can advise you if stopping this medication is appropriate. Beta-Blockers include: Atenolol (Tenormin), Metoprolol (Lopressor, Toprol), Nadolol (Corgard), Propranolol (Inderal)
- If you have any questions about your medications, please call your physician.
- You may eat prior to the test, but we advise you to only eat a light meal. A full stomach is not advisable.
During the Test
The physician will explain the test to you and answer any questions you may have. The physician will be present throughout the entire test. An intravenous (IV) line will be placed in your arm for the medication. Throughout the test, you will be closely monitored. The medication will be increased slowly until you reach a heart rate as if you were exercising.
Following the Test
- You will most likely be able to go home without any restrictions.
- Return to your medications that may have been stopped for the test.
- You may want to have a family member or friend drive you home.
If you have any questions, please call your physician
Related News and Articles
- Patient Education
- May | 24 | 2022
On May 24, 2022, the Massachusetts General Hospital Transplant Center held a virtual, fireside chat to share the latest updates on COVID-19 and transplantation.
- Press Release
- Apr | 18 | 2022
Women who had experienced infertility had a 16% increased risk of heart failure compared with women who did not have an infertility history.
- Press Release
- Mar | 3 | 2022
Handheld devices for A-fib screening may be most effective in the oldest adults during primary care visits
Advanced consumer technology has produced small electrocardiogram devices that could be efficiently deployed in point-of-care screening for atrial fibrillation, though the proportion of cases detected among all patients 65 and older is small.
- Press Release
- Mar | 2 | 2022
Mutations in genes that direct the production of fibrillar collagens, essential components of blood vessel walls, appear to predispose individuals to SCAD.
- Feb | 14 | 2022
Heart disease is the leading cause of death in men and women alike. In this presentation, Dr. Emily Lau reviews the epidemiology of heart disease in women, differences in heart disease between women and men, and special considerations for promoting female heart health.